Prostacyclin inhibition by indomethacin aggravates hepatic damage and encephalopathy in rats with thioacetamide-induced fulminant hepatic failure

Figure 1 Comparison of the degree of hepatic encephalopathy by total, ambulatory and vertical movement counts between rats with fulminant hepatic failure treated with indomethacin (n = 19) or N/S (n = 16).

Figure 2 Comparison of the plasma levels of 6-keto-PGF_1α, TNF-α, total bilirubin, and creatinine between rats with fulminant hepatic failure treated with indomethacin (n = 19) or N/S (n = 16).